BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,747,000 | +100.3% | 83,896 | +114.4% | 0.47% | +72.9% |
| Q2 2020 | $3,369,000 | -4.1% | 39,133 | -9.6% | 0.27% | -22.7% |
| Q1 2020 | $3,513,000 | -20.2% | 43,275 | -17.8% | 0.35% | +9.0% |
| Q4 2019 | $4,402,000 | -4.6% | 52,637 | -0.2% | 0.32% | -12.7% |
| Q3 2019 | $4,615,000 | +117.0% | 52,762 | +103.2% | 0.37% | +99.5% |
| Q2 2019 | $2,127,000 | -55.4% | 25,969 | -55.8% | 0.19% | -57.1% |
| Q1 2019 | $4,774,000 | -14.4% | 58,716 | -30.7% | 0.43% | -25.8% |
| Q4 2018 | $5,580,000 | -54.8% | 84,771 | -47.1% | 0.58% | -49.5% |
| Q3 2018 | $12,342,000 | -0.2% | 160,103 | -4.4% | 1.16% | -1.4% |
| Q2 2018 | $12,365,000 | -8.3% | 167,458 | -19.2% | 1.18% | -11.5% |
| Q1 2018 | $13,484,000 | -9.4% | 207,322 | -9.9% | 1.33% | -18.5% |
| Q4 2017 | $14,880,000 | -0.2% | 230,203 | -3.1% | 1.63% | -9.3% |
| Q3 2017 | $14,911,000 | +54.1% | 237,632 | +48.7% | 1.80% | +103.2% |
| Q2 2017 | $9,674,000 | – | 159,792 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |